1 / 8

Lupus Nephritis

Lupus Nephritis. Emily Chang April 13, 2010. The “Glom”. Classification. Based exclusively on glomerular pathology WHO classification last revised in 2004 Definitions Diffuse: involving >50% glomeruli Focal: involving <50% glomeruli

holleb
Download Presentation

Lupus Nephritis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Lupus Nephritis • Emily Chang • April 13, 2010

  2. The “Glom”

  3. Classification • Based exclusively on glomerular pathology • WHO classification last revised in 2004 • Definitions • Diffuse: involving >50% glomeruli • Focal: involving <50% glomeruli • Global: involving more than half of the glomerular tuft • Segmental: involving less than half of the glomerular tuft

  4. Other forms of Lupus Renal Disease • Tubulointerstitial nephritis: Severity of involvement is an important prognosticator. Almost always seen with concurrent glomerular disease. Sometimes it is the only manifestation of lupus nephritis. • Vascular disease: Presence can adversely affect prognosis of renal disease. Most frequently seen is immune complex deposition leading to vascular narrowing, immunoglobulin microvascular casts, TMA and vasculitis. • Drug-induced lupus: Hydralazine, procainamide, isoniazid.

  5. MKSAP • A 29 yo black woman comes for a routine exam. She has a 3-yr h/o SLE. She recently was diagnosed with a progressive kidney disease characterized by glomerular hematuria with dysmorphic erythrocytes and proteinuria. Over the past 3 weeks, her Cr has risen from 0.9 to 1.4. • Lab studies: C3 60, C4 8, ANA +, anti-ds-DNA + • Kidney biopsy reveals diffuse proliferative immune complex-laden glomerulonephritis with endothelial tubular reticular inclusion bodies.

  6. MKSAP, cont’d. • In addition to corticosteroid therapy, which of the following is the most appropriate treatment for this patient? • A. IV cyclophosphamide followed by maintenance IV cyclophosphamide. • B. IV cyclophosphamide followed by maintenance MMF. • C. Oral cyclophosphamide. • D. IV cyclophosphamide.

  7. References • Weening, Jan J. et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney International, Vol. 65 (2004), pp. 521-530. • Cotran, Ramzi S., Kumar, Vinay, Robbins, Stanley L. Robbins Basic Pathology, 7th edition. Saunders. 2003. • MKSAP 14. Nephrology. • utdol.com. Types of renal disease in systemic lupus erythematosus.

More Related